HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung cancer mortality and carbon black exposure: uncertainties of SMR analyses in a cohort study at a German carbon black production plant.

AbstractOBJECTIVE:
We undertook a sensitivity analysis of the lung cancer standardized mortality ratios (SMRs) in a study of 1522 German carbon black workers from 1976 to 1998.
METHODS:
We applied results from a case-control study to adjust the SMR for smoking habits and exposures experienced before the carbon black job. In addition, sensitivity to reference rates was explored.
RESULTS:
On the basis of 47 lung cancer deaths, the SMRs were 1.62, 1.72, and 2.08 (local, state, and national rates, respectively). Adjustment for previous exposures and smoking yielded additional correction factors of 0.64 or 0.74, varying with the chosen reference.
CONCLUSIONS:
Lung cancer SMRs (95% confidence intervals) for the full cohort ranged from 1.20 (0.88-1.59) to 2.08 (1.53-2.77) in this sensitivity analysis. Thus, overall SMRs are only weak measures of causal associations and should be complemented by internal modeling of exposure effects whenever possible.
AuthorsPeter Morfeld, Sebastian F Büchte, Robert J McCunney, Claus Piekarski, International Carbon Black Association
JournalJournal of occupational and environmental medicine (J Occup Environ Med) Vol. 48 Issue 12 Pg. 1253-64 (Dec 2006) ISSN: 1076-2752 [Print] United States
PMID17159642 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Soot
Topics
  • Case-Control Studies
  • Cohort Studies
  • Germany (epidemiology)
  • Humans
  • Industry
  • Logistic Models
  • Lung Neoplasms (etiology, mortality)
  • Male
  • Occupational Diseases (etiology, mortality)
  • Occupational Exposure (adverse effects, statistics & numerical data)
  • Smoking (adverse effects)
  • Soot (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: